United States · FDA National Drug Code directory
DULOXETINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-278_68db1bf0-65d7-4c3a-94ec-79209242a3d0
- Product NDC
- 62332-278
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Duloxetine
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260409
- Source listing expiry
- 20271231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-278-30) · 62332-278-30
- 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-278-60) · 62332-278-60
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-278-90) · 62332-278-90
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-278-91) · 62332-278-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →